A 62-year-old man with a 10-year history of chronic liver disease (Child-Pugh Class C) presents with spontaneous bleeding from esophageal varices. His prothrombin time is prolonged (INR 3.2), and platelet count is 65,000/μL. Which investigation is most appropriate to assess the hemostatic reserve and guide transfusion strategy in this patient?

## Hemostatic Assessment in Cirrhosis: Role of Viscoelastic Testing **Key Point:** Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) provide real-time, whole-blood assessment of hemostasis and are superior to conventional coagulation tests (PT/INR, aPTT) for guiding transfusion in cirrhosis. ### Why TEG/ROTEM is Correct In cirrhosis, conventional coagulation tests (PT/INR) are prolonged due to: - Decreased synthesis of procoagulants (factors II, V, VII, X) - Decreased synthesis of anticoagulants (protein C, protein S) - Thrombocytopenia (due to hypersplenism and bone marrow suppression) However, **the hemostatic balance is often preserved** because both procoagulant and anticoagulant pathways are impaired. TEG/ROTEM directly measures: - **R time (reaction time):** Initiation phase - **K time & angle:** Kinetics of clot formation - **MA (maximum amplitude):** Platelet contribution and clot strength - **LY30 (lysis at 30 min):** Fibrinolysis **High-Yield:** TEG/ROTEM-guided transfusion reduces unnecessary FFP/platelet transfusions and improves outcomes in cirrhotic patients with variceal bleeding compared to PT/INR-guided transfusion. **Clinical Pearl:** A prolonged INR in cirrhosis does NOT necessarily indicate severe coagulopathy; TEG/ROTEM may show adequate clot formation despite elevated INR. This explains why many cirrhotic patients do not bleed despite INR >3. ### Comparison of Hemostatic Tests in Cirrhosis | Test | What It Measures | Utility in Cirrhosis | |------|-----------------|---------------------| | PT/INR | Extrinsic pathway | Prognostic marker; NOT useful for transfusion decisions | | aPTT | Intrinsic pathway | Prolonged but not predictive of bleeding | | Fibrinogen | Clotting factor | Often low; not sole indicator of hemostasis | | Platelet count | Platelet number | Reduced by hypersplenism; does not reflect function | | TEG/ROTEM | Whole-blood clot formation & lysis | **Gold standard** for guiding transfusion; reflects true hemostatic balance | ### Why Other Investigations Are Inadequate - **Fibrinogen level:** Often low in cirrhosis but does not reflect overall hemostatic capacity; FFP transfusion based on fibrinogen alone is not evidence-based. - **Platelet aggregation studies:** Assess platelet function but are not routinely used in acute bleeding; platelet count is more relevant. - **Mixing study:** Used to differentiate factor deficiency from inhibitor in prolonged aPTT; not applicable here and does not guide transfusion strategy in cirrhosis.